5E Advanced Materials, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that 5E Advanced Materials, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($31.56M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($62.01M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($30.62M) | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | ($66.71M) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | ($19.25M) | Sep 28, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($43.72M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($35.86M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($36.71M) | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | ($67.83M) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | ($17.63M) | Sep 28, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $45.0K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $262.0K | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $133.0K | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $0 | Sep 28, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($23.64M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($26.87M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($30.70M) | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | ($28.62M) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | ($10.89M) | Sep 28, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $124.0K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $88.0K | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $352.0K | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $1.22M | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $39.0K | Sep 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $70.73M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $89.50M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $100.90M | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $70.89M | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $64.61M | Sep 28, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.54M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $78.80M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $47.33M | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $8.22M | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $2.28M | Sep 28, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $63.19M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $10.71M | Sep 29, 2025 |
| FY2025 | Jun 30, 2023 | $53.57M | Sep 29, 2025 |
| FY2024 | Jun 30, 2022 | $62.66M | Sep 9, 2024 |
| FY2023 | Jun 30, 2021 | $62.33M | Aug 30, 2023 |
| FY2022 | Jun 30, 2020 | $35.49M | Sep 28, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($231.56M) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | ($200.00M) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | ($137.99M) | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | ($107.36M) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | ($40.65M) | Sep 28, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.84M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $4.90M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $20.32M | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $31.06M | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $40.81M | Sep 28, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $22.0K | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | $64.83M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | $37.67M | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | $148.0K | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | $93.0K | Sep 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (3) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | (27) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (3) | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | (27) | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | (1) | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 28, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 20.02M | Sep 29, 2025 |
| FY2025 | Jun 30, 2024 | 2.75M | Sep 29, 2025 |
| FY2024 | Jun 30, 2023 | 63.32M | Sep 9, 2024 |
| FY2023 | Jun 30, 2022 | 43.31M | Aug 30, 2023 |
| FY2022 | Jun 30, 2021 | 38.39M | Sep 28, 2022 |